Trial Profile
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Jan 2019 Status changed from active, no longer recruiting to completed.
- 18 Sep 2017 Planned End Date changed from 1 Mar 2018 to 1 Oct 2018.
- 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.